NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCT1080220077

Registered date:08/09/2005

Basic Information

Recruitment status other
Health condition(s) or Problem(s) studiedGastric ulcer with Helicobacter pylori infection
Date of first enrollment08/09/2005
Target sample size300
Countries of recruitment
Study typeInterventional
Intervention(s)investigational material(s) Generic name etc : Polaprezinc INN of investigational material : Therapeutic category code : 232 Agents for peptic ulcer Dosage and Administration for Investigational material : Oral

Outcome(s)

Primary OutcomeThe time for healing of gastric ulcer
Secondary Outcome

Key inclusion & exclusion criteria

Age minimumNot applicable
Age maximumNot applicable
Gender
Include criteriaInclusion criteria -active gastric ulcer -single gastric ulcer Exclusion criteria -the patients who are eradicated Helicobacter pylori before
Exclude criteria

Related Information

Contact

Public contact
Name
Address kaihatu@zeria.co.jp
Telephone
E-mail
Affiliation ZERIA Pharmaceutical Co.,Ltd
Scientific contact
Name
Address
Telephone
E-mail
Affiliation